Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population.
Measurement of the serum alanine aminotransferase (ALT) level is used as an initial test for detection of liver diseases, and recent studies have also highlighted its potential value as a measure of overall health and survival as a marker of an increased risk of metabolic disorder. This study was designed to clarify the prevalence of elevated ALT levels in the Japanese population and to assess factors associated with ALT elevation. The subjects were 2165 individuals aged 40 to 85 years who participated in a Japanese community-based study referred to as the Takahata Study. Serum ALT levels and factors associated with ALT elevation were investigated. Among 2087 subjects who were negative for hepatitis B and C, the rates of elevated ALT greater than 30 U/L in men and greater than 25 U/L in women were 217 (22.7%) of 957 and 239 (21.2%) of 1130, respectively. These ALT cutoff levels had a specificity of more than 80% for exclusion of subjects with none or 1 of 3 metabolic risk factors: hypertension, lipid metabolism abnormality, and hyperglycemia. Multivariate analysis revealed 5 factors with a significant association with ALT elevation in men (n = 957): high gamma-glutamyltranspeptidase, low adiponectin, high low-density lipoprotein cholesterol, high body mass index, and high homeostasis model assessment insulin resistance index. Similarly, 4 factors were significantly associated with ALT elevation in women (n = 1130): high gamma-glutamyltranspeptidase, low adiponectin, high body mass index, and high homeostasis model assessment insulin resistance index. These results suggest that elevated ALT levels in the Japanese population older than 40 years have a strong association with metabolic syndrome-related features including obesity and insulin resistance.
Saito
Takafumi
T
Department of Gastroenterology, Yamagata University School of Medicine, Yamagata 990-9585, Japan. tasaitoh@med.id.yamagata-u.ac.jp
Nishise
Yuko
Y
Makino
Naohiko
N
Haga
Hiroaki
H
Ishii
Rika
R
Okumoto
Kazuo
K
Ito
Jun-Itsu
JI
Watanabe
Hisayoshi
H
Saito
Koji
K
Takeda
Hiroaki
H
Togashi
Hitoshi
H
Kubota
Isao
I
Daimon
Makoto
M
Kato
Takeo
T
Kawata
Sumio
S
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000410:Alanine Transaminase / Q000097:blood*; D000704:Analysis of Variance; D044466:Asian People; D015415:Biomarkers / Q000097:blood; D003430:Cross-Sectional Studies; D005260:Female; D006509:Hepatitis B / Q000150:complications / Q000276:immunology; D006526:Hepatitis C / Q000150:complications / Q000276:immunology; D006801:Humans; D007333:Insulin Resistance; D007564:Japan; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000201:enzymology*; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000201:enzymology*; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity
D015415:Biomarkers; D000410:Alanine Transaminase